Report Detail
Global Natural Killer (NK) Cell Therapeutics Market Insights, Forecast to 2025
- RnM2461451 |
- 22 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
The global Natural Killer (NK) Cell Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Natural Killer (NK) Cell Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Natural Killer (NK) Cell Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Natural Killer (NK) Cell Therapeutics in these regions.
This research report categorizes the global Natural Killer (NK) Cell Therapeutics market by top players/brands, region, type and end user. This report also studies the global Natural Killer (NK) Cell Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
Market size by Product
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market size by End User
Cancer
Cardiovascular Diseases
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Natural Killer (NK) Cell Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Natural Killer (NK) Cell Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Natural Killer (NK) Cell Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Natural Killer (NK) Cell Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Natural Killer (NK) Cell Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Product
- 1.4.2 Mogamulizumab
- 1.4.3 Lorvotuzumab Mertansine
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by End User
- 1.5.2 Cancer
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Natural Killer (NK) Cell Therapeutics Market Size
- 2.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue 2014-2025
- 2.1.2 Global Natural Killer (NK) Cell Therapeutics Sales 2014-2025
- 2.2 Natural Killer (NK) Cell Therapeutics Growth Rate by Regions
- 2.2.1 Global Natural Killer (NK) Cell Therapeutics Sales by Regions
- 2.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
- 3.1.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
- 3.1.2 Natural Killer (NK) Cell Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers
- 3.2.1 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Natural Killer (NK) Cell Therapeutics Price by Manufacturers
- 3.4 Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Natural Killer (NK) Cell Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Natural Killer (NK) Cell Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Natural Killer (NK) Cell Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Natural Killer (NK) Cell Therapeutics Sales by Product
- 4.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Product
- 4.3 Natural Killer (NK) Cell Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Natural Killer (NK) Cell Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Natural Killer (NK) Cell Therapeutics by Countries
- 6.1.1 North America Natural Killer (NK) Cell Therapeutics Sales by Countries
- 6.1.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Natural Killer (NK) Cell Therapeutics by Product
- 6.3 North America Natural Killer (NK) Cell Therapeutics by End User
7 Europe
- 7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
- 7.1.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Countries
- 7.1.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Natural Killer (NK) Cell Therapeutics by Product
- 7.3 Europe Natural Killer (NK) Cell Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Natural Killer (NK) Cell Therapeutics by Countries
- 8.1.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Natural Killer (NK) Cell Therapeutics by Product
- 8.3 Asia Pacific Natural Killer (NK) Cell Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Natural Killer (NK) Cell Therapeutics by Countries
- 9.1.1 Central & South America Natural Killer (NK) Cell Therapeutics Sales by Countries
- 9.1.2 Central & South America Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Natural Killer (NK) Cell Therapeutics by Product
- 9.3 Central & South America Natural Killer (NK) Cell Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Countries
- 10.1.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Product
- 10.3 Middle East and Africa Natural Killer (NK) Cell Therapeutics by End User
11 Company Profiles
- 11.1 Chipscreen Biosciences (China)
- 11.1.1 Chipscreen Biosciences (China) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.1.5 Chipscreen Biosciences (China) Recent Development
- 11.2 Affimed NV (Netherlands)
- 11.2.1 Affimed NV (Netherlands) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.2.5 Affimed NV (Netherlands) Recent Development
- 11.3 Altor BioScience Corporation (USA)
- 11.3.1 Altor BioScience Corporation (USA) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.3.5 Altor BioScience Corporation (USA) Recent Development
- 11.4 Innate Pharma SA (France)
- 11.4.1 Innate Pharma SA (France) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.4.5 Innate Pharma SA (France) Recent Development
- 11.5 Takeda Pharmaceutical (Japan)
- 11.5.1 Takeda Pharmaceutical (Japan) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.5.5 Takeda Pharmaceutical (Japan) Recent Development
- 11.6 Sorrento Therapeutics Inc. (USA)
- 11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
- 11.7 NantKwest Inc. (USA)
- 11.7.1 NantKwest Inc. (USA) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.7.5 NantKwest Inc. (USA) Recent Development
- 11.8 Bristol-Myers Squibb (USA)
- 11.8.1 Bristol-Myers Squibb (USA) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.8.5 Bristol-Myers Squibb (USA) Recent Development
- 11.9 NKT Therapeutics (USA)
- 11.9.1 NKT Therapeutics (USA) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Products Offered
- 11.9.5 NKT Therapeutics (USA) Recent Development
12 Future Forecast
- 12.1 Natural Killer (NK) Cell Therapeutics Market Forecast by Regions
- 12.1.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Natural Killer (NK) Cell Therapeutics Market Forecast by Product
- 12.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Natural Killer (NK) Cell Therapeutics Market Forecast by End User
- 12.4 North America Natural Killer (NK) Cell Therapeutics Forecast
- 12.5 Europe Natural Killer (NK) Cell Therapeutics Forecast
- 12.6 Asia Pacific Natural Killer (NK) Cell Therapeutics Forecast
- 12.7 Central & South America Natural Killer (NK) Cell Therapeutics Forecast
- 12.8 Middle East and Africa Natural Killer (NK) Cell Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Natural Killer (NK) Cell Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Natural Killer (NK) Cell Therapeutics . Industry analysis & Market Report on Natural Killer (NK) Cell Therapeutics is a syndicated market report, published as Global Natural Killer (NK) Cell Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Natural Killer (NK) Cell Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
